213 related articles for article (PubMed ID: 25858104)
1. Regulatory and clinical aspects of psychotropic medicinal products bioequivalence.
Bałkowiec-Iskra E; Cessak G; Kuzawińska O; Sejbuk-Rozbicka K; Rokita K; Mirowska-Guzel D
Eur Neuropsychopharmacol; 2015 Jul; 25(7):1027-34. PubMed ID: 25858104
[TBL] [Abstract][Full Text] [Related]
2. Rational use of generic psychotropic drugs.
Carbon M; Correll CU
CNS Drugs; 2013 May; 27(5):353-65. PubMed ID: 23620145
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of the switchability of generic products.
Karalis V; Bialer M; Macheras P
Eur J Pharm Sci; 2013 Nov; 50(3-4):476-83. PubMed ID: 23981332
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the bioavailability and bioequivalence of generic medications.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2010 Jan; 48(1):13-6. PubMed ID: 20102127
[TBL] [Abstract][Full Text] [Related]
5. [Generics in psychiatry--do they have the same therapeutic equivalence as the original?].
Kasper S; Lentner S
Neuropsychiatr; 2008; 22(4):221-2. PubMed ID: 19080992
[No Abstract] [Full Text] [Related]
6. United States Food and Drug Administration requirements for approval of generic drug products.
Meyer MC
J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846
[TBL] [Abstract][Full Text] [Related]
7. Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms.
Meredith PA
Curr Med Res Opin; 2009 Sep; 25(9):2179-89. PubMed ID: 19601710
[TBL] [Abstract][Full Text] [Related]
8. Current regulatory approaches of bioequivalence testing.
Karalis V; Macheras P
Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):929-42. PubMed ID: 22681436
[TBL] [Abstract][Full Text] [Related]
9. Generic versus brand name drugs in psychopharmacology: a pharmacoeconomic perspective.
Emanuele E
South Med J; 2011 Oct; 104(10):715-6. PubMed ID: 21941163
[No Abstract] [Full Text] [Related]
10. When is a "generic" medication not really a generic?
Howland RH
J Psychosoc Nurs Ment Health Serv; 2010 Feb; 48(2):13-6. PubMed ID: 20166651
[TBL] [Abstract][Full Text] [Related]
11. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
[TBL] [Abstract][Full Text] [Related]
12. Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability.
Bialer M; Midha KK
Epilepsia; 2010 Jun; 51(6):941-50. PubMed ID: 20384761
[TBL] [Abstract][Full Text] [Related]
13. Generics and cost-effective prescribing in Belgium: does bioequivalence always translate in therapeutic equivalence?
Dupont AG; Heller F
Acta Clin Belg; 2009; 64(5):406-14. PubMed ID: 19999388
[TBL] [Abstract][Full Text] [Related]
14. Determination of bioequivalence of psychotropic drugs and concerns involving product interchange.
Barone JA; Byerly WG
J Clin Psychiatry; 1986 Sep; 47 Suppl():28-32. PubMed ID: 2875067
[TBL] [Abstract][Full Text] [Related]
15. Variability and impact on design of bioequivalence studies.
Van Peer A
Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):146-53. PubMed ID: 20041877
[TBL] [Abstract][Full Text] [Related]
16. [Generic drugs: quality, efficacy, safety and interchangeability].
Tschabitscher D; Platzer P; Baumgärtel C; Müllner M
Wien Klin Wochenschr; 2008; 120(3-4):63-9. PubMed ID: 18322766
[TBL] [Abstract][Full Text] [Related]
17. [Bioequivalence studies of pharmaceutical preparations].
Vetchý D; Frýbortová K; Rabisková M; Danecková H
Cas Lek Cesk; 2007; 146(5):431-3. PubMed ID: 17554963
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe.
Odi R; Franco V; Perucca E; Bialer M
Epilepsia; 2021 Feb; 62(2):285-302. PubMed ID: 33426641
[TBL] [Abstract][Full Text] [Related]
19. Generics and substitution modalities: proposed methods for the evaluation of equivalence, traceability and pharmacovigilance reporting.
Lamarque V; Merle L; Demarez JP;
Therapie; 2008; 63(4):301-9. PubMed ID: 18937910
[TBL] [Abstract][Full Text] [Related]
20. Bioequivalence and narrow therapeutic index drugs.
Benet LZ; Goyan JE
Pharmacotherapy; 1995; 15(4):433-40. PubMed ID: 7479195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]